Protocol summary

Summary
Objective: The aim of this study is to evaluate the effects of treatment with vitamin D on thyroid function, metabolic markers and antithyroid antibodies in Hashimoto's thyroiditis patients with low serum vitamin D level. Design: This study is randomized double-blind placebo-Controlled trial Setting and conduct: The trial is undertaken in Isfahan endocrinology and metabolism research center. About 60 anti TPO positive euthyroid or hypothyroid persons with serum vitamin D level lower than 20 ng/ml are randomly assigned to receive vitamin D or placebo weekly for 12 weeks. Inclusion and exclusion criteria: All patients are between 20 to 60 year-old; anti TPO positive with vitamin D level lower than 20ng/ml; euthyroid or hypothyroid and more than six months using current prescriptions. We exclude patients who receive Insulin or immunosuppressive drugs or dietary supplementations; confounding comorbid disease and severe weight loss. Intervention: Blood samples will be obtained before trial and controls will receive placebo weekly for 12 weeks and target group will receive vitamin D 50000 unit weekly for 12 weeks.at the end second blood sample will be obtained. Main outcome measurements: Anti TPO (anti tissue peroxidase);TSH (thyroid stimulating hormone );fasting blood glucose; lipid profiles; calcium; phosphorus; albumin ;parathormone (PTH) ;urea ; creatinine and insulin are measured at the beginning and the end independent pair T test is used for between and within group analysis respectively .

General information

Acronym
IRCT registration information
IRCT registration number: IRCT2014120520216N1
Registration date: 2015-12-02, 1394/09/11
Registration timing: retrospective

Last update:
Update count: 0
Registration date
2015-12-02, 1394/09/11
Registrant information
Name
Parichehr Vahabi Anaraki
Name of organization / entity
Isfahan University of Medical Science; Department of Endocrinology
Country
Iran (Islamic Republic of)
Phone
+98 31 3669 7913
Email address
pari.vahabi@med.mui.ac.ir
Recruitment status
Recruitment complete
Funding source
Endocrinology Research Center, Isfahan University of Medical Science; Zahravy Pharmaceutical Company
Expected recruitment start date
2014-12-22, 1393/10/01
Expected recruitment end date
2015-03-20, 1393/12/29
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effects of treatment with vitamin D3 in Hashimoto's Thyroiditis with vitamin D deficiency on Thyroid function, antithyroid antibodies and metabolic markers
Public title
Effects of treatment with vitamin D3 in Hashimoto's Thyroiditis with vitamin D deficiency on Thyroid function, antithyroid antibodies and metabolic markers
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria: age 20 to 60 years; anti thyroid peroxidase antibody positive; serum 25 hydroxyl vitamin D 3 is less than 20 nanogram per milliliter; euthyroid or hypothyroid; if Levothyroxin or other metabolic drugs like Statins, Metformin consumed, starting time was more than 6 months ago. Exclusion criteria: immunosuppressor drugs intake before the study; dietary supplementation intake per oral or injections before study; comorbid disease ; severe weight loss; insulin taking.
Age
From 20 years old to 60 years old
Gender
Both
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features
The patient determines her or his group by drawing one closed envelope

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee, Isfahan University of Medical Science
Street address
Central Organization, Isfahan University of Medical Science, Hezar Jerib Boulevard
City
Isfahan
Postal code
Approval date
2014-09-23, 1393/07/01
Ethics committee reference number
394105

Health conditions studied

1

Description of health condition studied
Hashimoto's thyroiditis
ICD-10 code
E06.3
ICD-10 code description
Autoimmune thyroiditis: Hashimoto's thyroiditis, Temporary hashitoxicosis, Lymphadenoid thyroiditis, Lymphocytic thyroiditis, Lymphomatosis Stroma

Primary outcomes

1

Description
25, hydroxyl vitamin D3
Timepoint
before entering to the study & 12 weeks after drug or placebo consumption
Method of measurement
serum level measurement

2

Description
TPOAb
Timepoint
before entering to the study & 12 weeks after drug or placebo consumption
Method of measurement
serum level measurement

3

Description
Thyroid Stimulating Hormone (TSH)
Timepoint
before entering to the study & 12 weeks after drug or placebo consumption
Method of measurement
serum level measurement

Secondary outcomes

1

Description
Calcium
Timepoint
before entering to the study & 12 weeks after drug or placebo consumption
Method of measurement
serum level measurement

2

Description
PTH
Timepoint
before entering to the study & 12 weeks after drug or placebo consumption
Method of measurement
serum level measurement

Intervention groups

1

Description
intervention group 1: 50.000 units of Vitamin D prescription weekly and per oral for 12 weeks
Category
Treatment - Drugs

2

Description
control group: placebo prescription weekly per oral for 12 weeks
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
ٍEndocrinology research center; Sedigheh Tahereh Hospital
Full name of responsible person
Dr Parichehr Vahabi Anaraki
Street address
Khorram Street
City
Isfahan

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Vice Chancellor for research, Isfahan University of Medical Science
Full name of responsible person
Dr Mehdy Nematbakhsh
Street address
Vice Chancellor for research, No 4 Building, Isfahan University of Medical Science, Hezarjerib Street
City
Isfahan
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Vice Chancellor for research, Isfahan University of Medical Science
Proportion provided by this source
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

2

Sponsor
Name of organization / entity
Zahravi Pharmaceutical Company
Full name of responsible person
Dr Majeed Annabi
Street address
No 178, West Hoveyzeh St., Saboonchi St., Shahid Beheshti St.
City
Tehran
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Zahravi Pharmaceutical Company
Proportion provided by this source
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Isfahan University of Medical Science
Full name of responsible person
Dr Parichehr Vahabi Anaraki
Position
Endocrinology assistant
Other areas of specialty/work
Street address
Endocrinology Department, Alzahra Hospital
City
Isfahan
Postal code
Phone
+98 31 3669 7913
Fax
Email
pari.vahabi@med.mui.ac.ir
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Isfahan University of Medical Science, Endocrinology Department
Full name of responsible person
Dr Ashraf Aminorroaya
Position
MD, Endocrinologist
Other areas of specialty/work
Street address
Endocrinology Department, Alzahra Hospital
City
Isfahan
Postal code
Phone
+98 31 3441 1601
Fax
+98 31 3344 2908
Email
aminorroaya@med.mui.ac.ir
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Isfahan University of Medical Science
Full name of responsible person
Dr Parichehr Vahabi Anaraki
Position
Endocrinology assistant
Other areas of specialty/work
Street address
Endocrinology Department, Alzahra Hospital
City
Isfahan
Postal code
8168835443
Phone
+98 31 3669 7913
Fax
Email
pari.vahabi@med.mui.ac.ir
Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...